NCT02267707 2019-11-01
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Celgene
Phase 1 Terminated
Celgene
Conatus Pharmaceuticals Inc.